Cellulose
[대역어] 셀룰로오스
[용어속성] Compound
[용어속성] Compound
Comprehensive characterization of protective face coverings made from household fabrics
Research Article
[키워드] addition
aerosol
Aerosols
Cellulose
Combination
Comprehensive
Control
controls
coronavirus 2
coughing
COVID-19
droplet
droplets
effective
Efficiency
face
filtration
independent
methodology
mimicking
multiple mechanism
occur
offer
Pandemics
Protective
required
respiratory
respiratory virus
Result
reuse
SARS-CoV-2
Sodium chloride
submicron
transmitted
while
[DOI] 10.1371/journal.pone.0244626 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0244626 PMC 바로가기 [Article Type] Research Article
The effect of propolis supplementation on clinical symptoms in patients with coronavirus (COVID-19): A structured summary of a study protocol for a randomised controlled trial
코로나바이러스(COVID-19) 환자의 임상 증상에 대한 프로폴리스 보충제의 효과: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Randomized Controlled Trial
[키워드] 1:1
age
All participants
anticipated
Arm
baseline
Blinding
block size
calculated
categories
Cellulose
changes in
clinical
clinical symptom
Clinical symptoms
Clinicians
color
concealed
control group
coronavirus
coronavirus disease
COVID-19
Date
dissemination
double-blind
element
eligible
hospital
Intervention
intervention group
investigator
investigators
Iran
labelling
microcrystalline
microcrystalline cellulose
name
number
objective
odor
outcome
Parallel Arm
participant
Participants
Patient
patients
PCR test
performed
pharmaceutical
phase
Placebo
placebo-controlled clinical trial
Propolis
protocol
Protocol study
provided
randomised controlled trial
randomization
randomization list
randomization sequence
Randomized
Randomly
receive
recruited
Registered
registration number
Reyhan
Sample size
sealed
sensitivity
sequence
severity
Sex
shape
stratified
Study protocol
supplementary material
Tablet
Taste
total sample size
Trial
Trial registration
Version
Warfarin
website
weight
[DOI] 10.1186/s13063-020-04934-7 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1186/s13063-020-04934-7 PMC 바로가기 [Article Type] Randomized Controlled Trial
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 1:1
24 hour
Ability
absence
accompany
activity
Administered
administration
Admission
adverse events
Affect
age
alkaline phosphatase
allergy
ALT
alternative hypothesis
ambient
analysis
Analysis
ANC
Anti-inflammatory
anticipated
antipyretics
antivirals
Arm
ARMS
assumed
AST
Baltimore
baseline
benefit
blinded
block
block randomization
Blood
breastfeeding women
Bronchoalveolar lavage
calculated
Care
Cellulose
center
Chest
chest X-ray
childbearing potential
clinical
clinical condition
Clinical course
clinical impact
Clinical improvement
Clinical outcome
clinical status
clinical trial
collected
competing
Compliance
concealed
Concentration
Concomitant
conditions
conducted
congestive heart failure
Contraception
Control
control arm
Conventional
Corticosteroids
COVID-19
COVID-19 disease
COVID-19 infection
COVID-19 pandemic
criteria
criterion
Critical
CT scan
current
Day
Declaration of Helsinki
decrease
defined
detect
direct bilirubin
disease
disorder
dissemination
dose
double-blind
drug
Drug administration
drug-drug interaction
drugs
Duration
ECMO
Efficacy
Efficacy and safety
element
eligible
endosomal pH
Enrollment
ethnic group
evaluate
Evidence
exclusion
expected
exploratory endpoint
extracorporeal membrane oxygenation
Face mask
FDA
Fisher
Good
group
handling
harmonization
hematologic
histocompatibility complex
Hospitalization
Hospitalized
hospitalized patient
Hydroxychloroquine
Hypothesis
ICU
IL-6 levels
Imatinib
immunomodulatory
immunomodulatory drugs
IND
information
Informed consent
inhibitory activity
intensive care
intensive care unit
intention to treat
interfere
International Conference
invasive
Invasive mechanical ventilation
investigational agent
investigator
ITT
Laboratory
Last
limit
limitation
liver
Local
lysosomal sequestration
magnitude
matching placebo
mechanical ventilation
men and women
MHC
mononuclear cell
Mortality
nasal
nasopharyngeal
Nasopharyngeal swab
neutrophil count
New
new oxygen use
non-invasive ventilation
non-rebreather mask
not blinded
null hypothesis
number
objective
off-label
off-label use
Oropharyngeal
outcome
outcomes
oxygen
Oxygenation
P450
packaged
PaO
participant
Participants
Patient
patients
patients with ARDS
patients with COVID-19
PBMCs
performed
Pharmacist
Pharmacy
phase 3 study
Placebo
placebo-controlled
Pneumonia
positive COVID-19
Practice
primary analysis
primary endpoint
principal
progression
proportion
protocol
Psychiatric
Radiographic
random number generator
randomised controlled trial
randomization
Randomized
Randomized controlled trial
receive
receiving
recruitment
Regulatory
renal dysfunction
renal replacement therapy
replication of SARS-CoV-2
required
requiring supplemental oxygen
Respiratory illness
respiratory tract
risk
RT-PCR
Safety
Sample size
sarilumab
SARS-CoV
SARS-CoV-2
secondary endpoint
Seizure
Serious Adverse Events
service
severe disease
severity
significance level
Site
Society
stability
Standard of care
status
stratified
study drug
study enrollment
study outcomes
Study protocol
subject
submitted
supplemental oxygen
Support
Suspension
symptomatic
Tablet
temperature
Test
the patient
the primary endpoint
time
TKI
TKI-induced attenuation of vascular leak
TKI-induced prevention and treatment lung inflammation
Tocilizumab
transcriptomics
Treatment
treatment allocation
treatment arm
treatments for COVID-19
Trial
two-sided
tyrosine kinase inhibitor
uncontrolled
university
unstable angina
vasopressors
ventilator
ventilator free days
viral ABL-1 signalling
website
with COVID-19
[DOI] 10.1186/s13063-020-04819-9 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04819-9 PMC 바로가기 [Article Type] Letter
Propagation, Inactivation, and Safety Testing of SARS-CoV-2
Article
[키워드] acute respiratory syndrome
Biosafety Level 3
causes
Cellulose
Chinese
coronavirus
COVID-19
deaths
described
DNA
effective
facilitated
focus forming assay
inactivation
infected cell
Infection
Infectious virus
multiple cell line
neutral buffered formalin
new virus
Novel coronavirus
pandemic
performed
Plaque assay
Propagation
Protein
quantification
Research
responsible
resulting
RNA
Safe
Safety
SARS-CoV-2
Testing
the disease
Trizol
Virology
virus
virus infectivity
widespread
worldwide pandemic
Wuhan
[DOI] 10.3390/v12060622 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/v12060622 PMC 바로가기 [Article Type] Article
Parallel evolution leading to impaired biofilm formation in invasive Salmonella strains
침습성 살모넬라 균주에서 손상된 생물막 형성으로 이어지는 병렬 진화
Research Article
[키워드] acting
African
Amino acid
amino acids
Analysis
Author
biofilm
C-terminus
caused
Cellulose
children
clade
clinician
colonize
comparison
conserved
death
disease
eight
environmental niche
environmental reservoir
environmental reservoirs
Evidence
Evolution
Fever
food supply
gastroenteritis
gene mutation
Genotype
Health
Host
hosts
humans
hygiene
impairment
Infection
intestine
intestines
invasive
invasive disease
investigated
isolate
isolates
less
Lineage
lineages
NTS
organism
parallel evolution
Pathogens
phenotype
Phylogenetic analysis
Prevent
profile
promoter region
Public
raise
reduced
reducing
Regulatory
replicate
reporter
researcher
retained
Salmonella
Salmonella Enteritidis
Salmonella Typhi
Salmonella Typhimurium
salmonellosis
SNP
strain
Strains
structural gene
Structure
Support
survival
systemic infections
Transcription
Transmission
truncation
typhoid fever
water
[DOI] 10.1371/journal.pgen.1008233 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pgen.1008233 PMC 바로가기 [Article Type] Research Article